65,437 trials
Stress Urinary Incontinence (SUI)
Primary: Percentage of Responders for Pad Weight Gain or SUI Episodes — 69 percentage of subjects
Hypertension
Primary: Plasma Nitric Oxide Level Change From Baseline to Month 12 Between the Groups. — 11.47; -17.27 percent change
Poor Peripheral Perfusion
Primary: MRI Based Radial Artery Measurement — 1.35 millimeters
Active Polyarticular Juvenile Idiopathic Arthritis
Primary: Abatacept Trough Concentration (Cmin) in Participants Ages 6 to 17 — 39.7 µg/mL
Alzheimer Disease · Dementia
Primary: FCI Score at Follow-up — 147.3; 164.0; 123.3; 150.8 points awarded for correct items
Total Fluid Volume Increased
Primary: Concentration of NGAL in Urine on 5 Time Point — 5.6; 4.9; 5.2; 5.1 ng/ml
Papillon-Lefevre Disease
Primary: Serum Concentrations of Interleukin (IL)-1 Beta — 1100.00; 896.21; 65559; 45734 pg/ml
Stress Urinary Incontinence
Primary: Change in Pad Weight Gain — 2.67 grams/usage period
Huntington Disease
Primary: Ratio of Inorganic Phosphate (Pi) Over Phosphocreatine (PCr): Pi/PCr — 0.44; 0.43; 0.44; 0.42 ratio
Dry Eye Syndromes
Primary: Sustained Silent Reading Speed — 248.4; 270.3 words/minute
Healthy Volunteers
Primary: Baseline and Peak TNF-alpha Values as Categorized by Race and Gender — 1.08; 43.48; 1.03; 37.28 pg/ml
Multiple Myeloma
Primary: Rate of Patients Achieving a Response Based on M-protein or Free Light Chains — 0; 1 participants
Lymphoma, T-Cell, Cutaneous
Primary: Percentage of Patients With Complete or Partial Response as Measured by Change in Lesion Severity Using CAILS (Composite Assessment of Index Lesion Severity) — 27; 0…
Ageing
Primary: Evaluate Overall Facial Improvement Assessed Live by the Investigator and Subjects Using the Global Aesthetic Improvement Scale (GAIS) at 12 Weeks Compared to Baseline…
Dry Eye
Primary: Change From Baseline in TFBUT at Day 35 — 1.5; 0.5 seconds